世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
高性能血液・輸液ウォーマーの世界市場成長 2023-2029Global High-Performance Blood and Infusion Warmer Market Growth 2023-2029 LPI（LPインフォメーション）の最新調査によると、高性能血液・輸液ウォーマーの世界市場規模は2022年に6億5,640万米ドルとなった。下流市場での需要拡大に伴い、高性能血液・輸液ウォーマーは2029年までに1億294... もっと見る
日本語のページは自動翻訳を利用し作成しています。 
サマリーLPI（LPインフォメーション）の最新調査によると、高性能血液・輸液ウォーマーの世界市場規模は2022年に6億5,640万米ドルとなった。下流市場での需要拡大に伴い、高性能血液・輸液ウォーマーは2029年までに1億2940万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは6.6%である。この調査レポートは、世界の高性能血液・輸液ウォーマー市場の成長可能性を明らかにしています。高性能血液・輸液ウォーマーは今後の市場でも安定した成長が見込まれる。しかし、高性能血液・輸液ウォーマーの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要です。市場関係者は、高性能血液・輸液ウォーマー市場がもたらす莫大な機会を活用するために、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供を行う必要がある。 主な特徴 この調査レポートは、高性能血液・輸液ウォーマー市場の様々な側面を反映し、業界に関する貴重な洞察を提供しています。 市場規模と成長：この調査レポートは、高性能血液・輸液ウォーマー市場の現在の規模と成長の概要を提供します。過去のデータ、タイプ別（携帯型、据え置き型など）の市場細分化、地域別内訳などが含まれます。 市場促進要因と課題：政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、高性能血液・輸液ウォーマー市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制約、航続距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。 競合情勢：この調査レポートは、高性能血液・輸液ウォーマー市場における競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。 技術開発：調査レポートは、高性能血液・輸液ウォーマー産業における最新の技術開発を掘り下げることができます。これには、高性能血液・輸液ウォーマー技術の進歩、高性能血液・輸液ウォーマーの新規参入企業、高性能血液・輸液ウォーマーの新規投資、高性能血液・輸液ウォーマーの将来を形作るその他の技術革新が含まれます。 川下企業の好み：このレポートは、高性能血液・輸液ウォーマー市場における顧客の購買行動と採用動向を明らかにします。顧客の購買決定や高性能血液・輸液ウォーマー製品の嗜好に影響を与える要因も含まれています。 政府の政策とインセンティブこの調査レポートは、政府の政策とインセンティブが高性能血液・輸液ウォーマー市場に与える影響を分析しています。これには、高性能血液・輸液ウォーマー市場の促進を目的とした規制の枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性についても評価します。 環境への影響と持続可能性調査レポートは、高性能血液・輸液ウォーマー市場の環境影響と持続可能性の側面を評価します。 市場予測と将来展望：調査レポートでは、実施した分析に基づいて、高性能血液・輸液ウォーマー産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会：本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、高性能血液・輸液ウォーマー市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 高性能血液・輸液ウォーマー市場は、タイプ別と用途別に分類される。2018-2029年の期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。 タイプ別セグメント ポータブル 据え置き型 用途別セグメント 手術室（OR） 救急部（ED） 集中治療室（ICU） 分娩室 回復室 軍病院および野戦病院 その他 本レポートではまた、市場を地域別に分けています： 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ストライカー スミスメディカル ベクトン・ディッキンソン・アンド・カンパニー（BD） 3Mヘルスケア ベルモント インストゥルメント コーポレーション エンサーミクス・メディカル・システムズ バーキーGmbH & Co.KG スミスグループ（スミスディテクション） サハジャナンド・メディカル・テクノロジーズ パーカーヘルスケア GEヘルスケア ザ・サージカル・カンパニー バクスター・インターナショナル インスピレーション・ヘルスケア・グループ スティーラー・エレクトロニック タハト・アクシ・アルク ビーグラー エースメディカル エミット・コーポレーション 佛山キーウェル メディカルテクノロジーLBI ゲンテルム・メディカル ガミダ ミッドマークアニマルヘルス エンジェル・カナダ・エンタープライズ シノ・メディカル・デバイス・テクノロジー 深センEtメディカルテクノロジー 本レポートで扱う主な質問 高性能血液・輸液ウォーマーの世界市場の10年見通しは？ 高性能血液・輸液ウォーマーの世界および地域別市場成長の要因は何か？ 市場別・地域別に最も急成長する技術は何か？ 高性能血液・輸液ウォーマーの市場機会は最終市場規模によってどのように異なるのか？ 高性能血液・輸液ウォーマーのタイプ別、用途別内訳は？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global High-Performance Blood and Infusion Warmer Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for High-Performance Blood and Infusion Warmer by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for High-Performance Blood and Infusion Warmer by Country/Region, 2018, 2022 & 2029 2.2 High-Performance Blood and Infusion Warmer Segment by Type 2.2.1 Portable 2.2.2 Stationary 2.3 High-Performance Blood and Infusion Warmer Sales by Type 2.3.1 Global High-Performance Blood and Infusion Warmer Sales Market Share by Type (2018-2023) 2.3.2 Global High-Performance Blood and Infusion Warmer Revenue and Market Share by Type (2018-2023) 2.3.3 Global High-Performance Blood and Infusion Warmer Sale Price by Type (2018-2023) 2.4 High-Performance Blood and Infusion Warmer Segment by Application 2.4.1 Operating Rooms (ORs) 2.4.2 Emergency Departments (EDs) 2.4.3 Intensive Care Units (ICUs) 2.4.4 Labor and Delivery Units 2.4.5 Recovery Rooms 2.4.6 Military and Field Hospitals 2.4.7 Others 2.5 High-Performance Blood and Infusion Warmer Sales by Application 2.5.1 Global High-Performance Blood and Infusion Warmer Sale Market Share by Application (2018-2023) 2.5.2 Global High-Performance Blood and Infusion Warmer Revenue and Market Share by Application (2018-2023) 2.5.3 Global High-Performance Blood and Infusion Warmer Sale Price by Application (2018-2023) 3 Global High-Performance Blood and Infusion Warmer by Company 3.1 Global High-Performance Blood and Infusion Warmer Breakdown Data by Company 3.1.1 Global High-Performance Blood and Infusion Warmer Annual Sales by Company (2018-2023) 3.1.2 Global High-Performance Blood and Infusion Warmer Sales Market Share by Company (2018-2023) 3.2 Global High-Performance Blood and Infusion Warmer Annual Revenue by Company (2018-2023) 3.2.1 Global High-Performance Blood and Infusion Warmer Revenue by Company (2018-2023) 3.2.2 Global High-Performance Blood and Infusion Warmer Revenue Market Share by Company (2018-2023) 3.3 Global High-Performance Blood and Infusion Warmer Sale Price by Company 3.4 Key Manufacturers High-Performance Blood and Infusion Warmer Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers High-Performance Blood and Infusion Warmer Product Location Distribution 3.4.2 Players High-Performance Blood and Infusion Warmer Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for High-Performance Blood and Infusion Warmer by Geographic Region 4.1 World Historic High-Performance Blood and Infusion Warmer Market Size by Geographic Region (2018-2023) 4.1.1 Global High-Performance Blood and Infusion Warmer Annual Sales by Geographic Region (2018-2023) 4.1.2 Global High-Performance Blood and Infusion Warmer Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic High-Performance Blood and Infusion Warmer Market Size by Country/Region (2018-2023) 4.2.1 Global High-Performance Blood and Infusion Warmer Annual Sales by Country/Region (2018-2023) 4.2.2 Global High-Performance Blood and Infusion Warmer Annual Revenue by Country/Region (2018-2023) 4.3 Americas High-Performance Blood and Infusion Warmer Sales Growth 4.4 APAC High-Performance Blood and Infusion Warmer Sales Growth 4.5 Europe High-Performance Blood and Infusion Warmer Sales Growth 4.6 Middle East & Africa High-Performance Blood and Infusion Warmer Sales Growth 5 Americas 5.1 Americas High-Performance Blood and Infusion Warmer Sales by Country 5.1.1 Americas High-Performance Blood and Infusion Warmer Sales by Country (2018-2023) 5.1.2 Americas High-Performance Blood and Infusion Warmer Revenue by Country (2018-2023) 5.2 Americas High-Performance Blood and Infusion Warmer Sales by Type 5.3 Americas High-Performance Blood and Infusion Warmer Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC High-Performance Blood and Infusion Warmer Sales by Region 6.1.1 APAC High-Performance Blood and Infusion Warmer Sales by Region (2018-2023) 6.1.2 APAC High-Performance Blood and Infusion Warmer Revenue by Region (2018-2023) 6.2 APAC High-Performance Blood and Infusion Warmer Sales by Type 6.3 APAC High-Performance Blood and Infusion Warmer Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe High-Performance Blood and Infusion Warmer by Country 7.1.1 Europe High-Performance Blood and Infusion Warmer Sales by Country (2018-2023) 7.1.2 Europe High-Performance Blood and Infusion Warmer Revenue by Country (2018-2023) 7.2 Europe High-Performance Blood and Infusion Warmer Sales by Type 7.3 Europe High-Performance Blood and Infusion Warmer Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa High-Performance Blood and Infusion Warmer by Country 8.1.1 Middle East & Africa High-Performance Blood and Infusion Warmer Sales by Country (2018-2023) 8.1.2 Middle East & Africa High-Performance Blood and Infusion Warmer Revenue by Country (2018-2023) 8.2 Middle East & Africa High-Performance Blood and Infusion Warmer Sales by Type 8.3 Middle East & Africa High-Performance Blood and Infusion Warmer Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of High-Performance Blood and Infusion Warmer 10.3 Manufacturing Process Analysis of High-Performance Blood and Infusion Warmer 10.4 Industry Chain Structure of High-Performance Blood and Infusion Warmer 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 High-Performance Blood and Infusion Warmer Distributors 11.3 High-Performance Blood and Infusion Warmer Customer 12 World Forecast Review for High-Performance Blood and Infusion Warmer by Geographic Region 12.1 Global High-Performance Blood and Infusion Warmer Market Size Forecast by Region 12.1.1 Global High-Performance Blood and Infusion Warmer Forecast by Region (2024-2029) 12.1.2 Global High-Performance Blood and Infusion Warmer Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global High-Performance Blood and Infusion Warmer Forecast by Type 12.7 Global High-Performance Blood and Infusion Warmer Forecast by Application 13 Key Players Analysis 13.1 Stryker 13.1.1 Stryker Company Information 13.1.2 Stryker High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.1.3 Stryker High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Stryker Main Business Overview 13.1.5 Stryker Latest Developments 13.2 Smiths Medical 13.2.1 Smiths Medical Company Information 13.2.2 Smiths Medical High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.2.3 Smiths Medical High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Smiths Medical Main Business Overview 13.2.5 Smiths Medical Latest Developments 13.3 Becton, Dickinson and Company (BD) 13.3.1 Becton, Dickinson and Company (BD) Company Information 13.3.2 Becton, Dickinson and Company (BD) High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.3.3 Becton, Dickinson and Company (BD) High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Becton, Dickinson and Company (BD) Main Business Overview 13.3.5 Becton, Dickinson and Company (BD) Latest Developments 13.4 3M Healthcare 13.4.1 3M Healthcare Company Information 13.4.2 3M Healthcare High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.4.3 3M Healthcare High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 3M Healthcare Main Business Overview 13.4.5 3M Healthcare Latest Developments 13.5 Belmont Instrument Corporation 13.5.1 Belmont Instrument Corporation Company Information 13.5.2 Belmont Instrument Corporation High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.5.3 Belmont Instrument Corporation High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Belmont Instrument Corporation Main Business Overview 13.5.5 Belmont Instrument Corporation Latest Developments 13.6 Enthermics Medical Systems 13.6.1 Enthermics Medical Systems Company Information 13.6.2 Enthermics Medical Systems High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.6.3 Enthermics Medical Systems High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Enthermics Medical Systems Main Business Overview 13.6.5 Enthermics Medical Systems Latest Developments 13.7 Barkey GmbH & Co. KG 13.7.1 Barkey GmbH & Co. KG Company Information 13.7.2 Barkey GmbH & Co. KG High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.7.3 Barkey GmbH & Co. KG High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Barkey GmbH & Co. KG Main Business Overview 13.7.5 Barkey GmbH & Co. KG Latest Developments 13.8 Smiths Group (Smiths Detection) 13.8.1 Smiths Group (Smiths Detection) Company Information 13.8.2 Smiths Group (Smiths Detection) High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.8.3 Smiths Group (Smiths Detection) High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Smiths Group (Smiths Detection) Main Business Overview 13.8.5 Smiths Group (Smiths Detection) Latest Developments 13.9 Sahajanand Medical Technologies 13.9.1 Sahajanand Medical Technologies Company Information 13.9.2 Sahajanand Medical Technologies High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.9.3 Sahajanand Medical Technologies High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Sahajanand Medical Technologies Main Business Overview 13.9.5 Sahajanand Medical Technologies Latest Developments 13.10 Parker Healthcare 13.10.1 Parker Healthcare Company Information 13.10.2 Parker Healthcare High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.10.3 Parker Healthcare High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Parker Healthcare Main Business Overview 13.10.5 Parker Healthcare Latest Developments 13.11 GE Healthcare 13.11.1 GE Healthcare Company Information 13.11.2 GE Healthcare High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.11.3 GE Healthcare High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 GE Healthcare Main Business Overview 13.11.5 GE Healthcare Latest Developments 13.12 The Surgical Company 13.12.1 The Surgical Company Company Information 13.12.2 The Surgical Company High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.12.3 The Surgical Company High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 The Surgical Company Main Business Overview 13.12.5 The Surgical Company Latest Developments 13.13 Baxter International 13.13.1 Baxter International Company Information 13.13.2 Baxter International High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.13.3 Baxter International High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Baxter International Main Business Overview 13.13.5 Baxter International Latest Developments 13.14 Inspiration Healthcare Group 13.14.1 Inspiration Healthcare Group Company Information 13.14.2 Inspiration Healthcare Group High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.14.3 Inspiration Healthcare Group High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Inspiration Healthcare Group Main Business Overview 13.14.5 Inspiration Healthcare Group Latest Developments 13.15 Stihler Electronic 13.15.1 Stihler Electronic Company Information 13.15.2 Stihler Electronic High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.15.3 Stihler Electronic High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Stihler Electronic Main Business Overview 13.15.5 Stihler Electronic Latest Developments 13.16 TahatAksi ALC 13.16.1 TahatAksi ALC Company Information 13.16.2 TahatAksi ALC High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.16.3 TahatAksi ALC High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 TahatAksi ALC Main Business Overview 13.16.5 TahatAksi ALC Latest Developments 13.17 Biegler 13.17.1 Biegler Company Information 13.17.2 Biegler High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.17.3 Biegler High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 Biegler Main Business Overview 13.17.5 Biegler Latest Developments 13.18 ACE Medical 13.18.1 ACE Medical Company Information 13.18.2 ACE Medical High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.18.3 ACE Medical High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 ACE Medical Main Business Overview 13.18.5 ACE Medical Latest Developments 13.19 Emit Corporation 13.19.1 Emit Corporation Company Information 13.19.2 Emit Corporation High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.19.3 Emit Corporation High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 Emit Corporation Main Business Overview 13.19.5 Emit Corporation Latest Developments 13.20 Foshan Keewell 13.20.1 Foshan Keewell Company Information 13.20.2 Foshan Keewell High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.20.3 Foshan Keewell High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.20.4 Foshan Keewell Main Business Overview 13.20.5 Foshan Keewell Latest Developments 13.21 Medical Technologies LBI 13.21.1 Medical Technologies LBI Company Information 13.21.2 Medical Technologies LBI High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.21.3 Medical Technologies LBI High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.21.4 Medical Technologies LBI Main Business Overview 13.21.5 Medical Technologies LBI Latest Developments 13.22 Gentherm Medical 13.22.1 Gentherm Medical Company Information 13.22.2 Gentherm Medical High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.22.3 Gentherm Medical High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.22.4 Gentherm Medical Main Business Overview 13.22.5 Gentherm Medical Latest Developments 13.23 Gamida 13.23.1 Gamida Company Information 13.23.2 Gamida High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.23.3 Gamida High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.23.4 Gamida Main Business Overview 13.23.5 Gamida Latest Developments 13.24 Midmark Animal Health 13.24.1 Midmark Animal Health Company Information 13.24.2 Midmark Animal Health High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.24.3 Midmark Animal Health High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.24.4 Midmark Animal Health Main Business Overview 13.24.5 Midmark Animal Health Latest Developments 13.25 Angel Canada Enterprises 13.25.1 Angel Canada Enterprises Company Information 13.25.2 Angel Canada Enterprises High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.25.3 Angel Canada Enterprises High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.25.4 Angel Canada Enterprises Main Business Overview 13.25.5 Angel Canada Enterprises Latest Developments 13.26 Sino Medical-Device Technology 13.26.1 Sino Medical-Device Technology Company Information 13.26.2 Sino Medical-Device Technology High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.26.3 Sino Medical-Device Technology High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.26.4 Sino Medical-Device Technology Main Business Overview 13.26.5 Sino Medical-Device Technology Latest Developments 13.27 Shenzhen Et Medical Technology 13.27.1 Shenzhen Et Medical Technology Company Information 13.27.2 Shenzhen Et Medical Technology High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.27.3 Shenzhen Et Medical Technology High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.27.4 Shenzhen Et Medical Technology Main Business Overview 13.27.5 Shenzhen Et Medical Technology Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global High-Performance Blood and Infusion Warmer market size was valued at US$ 656.4 million in 2022. With growing demand in downstream market, the High-Performance Blood and Infusion Warmer is forecast to a readjusted size of US$ 1029.4 million by 2029 with a CAGR of 6.6% during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global High-Performance Blood and Infusion Warmer Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for High-Performance Blood and Infusion Warmer by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for High-Performance Blood and Infusion Warmer by Country/Region, 2018, 2022 & 2029 2.2 High-Performance Blood and Infusion Warmer Segment by Type 2.2.1 Portable 2.2.2 Stationary 2.3 High-Performance Blood and Infusion Warmer Sales by Type 2.3.1 Global High-Performance Blood and Infusion Warmer Sales Market Share by Type (2018-2023) 2.3.2 Global High-Performance Blood and Infusion Warmer Revenue and Market Share by Type (2018-2023) 2.3.3 Global High-Performance Blood and Infusion Warmer Sale Price by Type (2018-2023) 2.4 High-Performance Blood and Infusion Warmer Segment by Application 2.4.1 Operating Rooms (ORs) 2.4.2 Emergency Departments (EDs) 2.4.3 Intensive Care Units (ICUs) 2.4.4 Labor and Delivery Units 2.4.5 Recovery Rooms 2.4.6 Military and Field Hospitals 2.4.7 Others 2.5 High-Performance Blood and Infusion Warmer Sales by Application 2.5.1 Global High-Performance Blood and Infusion Warmer Sale Market Share by Application (2018-2023) 2.5.2 Global High-Performance Blood and Infusion Warmer Revenue and Market Share by Application (2018-2023) 2.5.3 Global High-Performance Blood and Infusion Warmer Sale Price by Application (2018-2023) 3 Global High-Performance Blood and Infusion Warmer by Company 3.1 Global High-Performance Blood and Infusion Warmer Breakdown Data by Company 3.1.1 Global High-Performance Blood and Infusion Warmer Annual Sales by Company (2018-2023) 3.1.2 Global High-Performance Blood and Infusion Warmer Sales Market Share by Company (2018-2023) 3.2 Global High-Performance Blood and Infusion Warmer Annual Revenue by Company (2018-2023) 3.2.1 Global High-Performance Blood and Infusion Warmer Revenue by Company (2018-2023) 3.2.2 Global High-Performance Blood and Infusion Warmer Revenue Market Share by Company (2018-2023) 3.3 Global High-Performance Blood and Infusion Warmer Sale Price by Company 3.4 Key Manufacturers High-Performance Blood and Infusion Warmer Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers High-Performance Blood and Infusion Warmer Product Location Distribution 3.4.2 Players High-Performance Blood and Infusion Warmer Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for High-Performance Blood and Infusion Warmer by Geographic Region 4.1 World Historic High-Performance Blood and Infusion Warmer Market Size by Geographic Region (2018-2023) 4.1.1 Global High-Performance Blood and Infusion Warmer Annual Sales by Geographic Region (2018-2023) 4.1.2 Global High-Performance Blood and Infusion Warmer Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic High-Performance Blood and Infusion Warmer Market Size by Country/Region (2018-2023) 4.2.1 Global High-Performance Blood and Infusion Warmer Annual Sales by Country/Region (2018-2023) 4.2.2 Global High-Performance Blood and Infusion Warmer Annual Revenue by Country/Region (2018-2023) 4.3 Americas High-Performance Blood and Infusion Warmer Sales Growth 4.4 APAC High-Performance Blood and Infusion Warmer Sales Growth 4.5 Europe High-Performance Blood and Infusion Warmer Sales Growth 4.6 Middle East & Africa High-Performance Blood and Infusion Warmer Sales Growth 5 Americas 5.1 Americas High-Performance Blood and Infusion Warmer Sales by Country 5.1.1 Americas High-Performance Blood and Infusion Warmer Sales by Country (2018-2023) 5.1.2 Americas High-Performance Blood and Infusion Warmer Revenue by Country (2018-2023) 5.2 Americas High-Performance Blood and Infusion Warmer Sales by Type 5.3 Americas High-Performance Blood and Infusion Warmer Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC High-Performance Blood and Infusion Warmer Sales by Region 6.1.1 APAC High-Performance Blood and Infusion Warmer Sales by Region (2018-2023) 6.1.2 APAC High-Performance Blood and Infusion Warmer Revenue by Region (2018-2023) 6.2 APAC High-Performance Blood and Infusion Warmer Sales by Type 6.3 APAC High-Performance Blood and Infusion Warmer Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe High-Performance Blood and Infusion Warmer by Country 7.1.1 Europe High-Performance Blood and Infusion Warmer Sales by Country (2018-2023) 7.1.2 Europe High-Performance Blood and Infusion Warmer Revenue by Country (2018-2023) 7.2 Europe High-Performance Blood and Infusion Warmer Sales by Type 7.3 Europe High-Performance Blood and Infusion Warmer Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa High-Performance Blood and Infusion Warmer by Country 8.1.1 Middle East & Africa High-Performance Blood and Infusion Warmer Sales by Country (2018-2023) 8.1.2 Middle East & Africa High-Performance Blood and Infusion Warmer Revenue by Country (2018-2023) 8.2 Middle East & Africa High-Performance Blood and Infusion Warmer Sales by Type 8.3 Middle East & Africa High-Performance Blood and Infusion Warmer Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of High-Performance Blood and Infusion Warmer 10.3 Manufacturing Process Analysis of High-Performance Blood and Infusion Warmer 10.4 Industry Chain Structure of High-Performance Blood and Infusion Warmer 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 High-Performance Blood and Infusion Warmer Distributors 11.3 High-Performance Blood and Infusion Warmer Customer 12 World Forecast Review for High-Performance Blood and Infusion Warmer by Geographic Region 12.1 Global High-Performance Blood and Infusion Warmer Market Size Forecast by Region 12.1.1 Global High-Performance Blood and Infusion Warmer Forecast by Region (2024-2029) 12.1.2 Global High-Performance Blood and Infusion Warmer Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global High-Performance Blood and Infusion Warmer Forecast by Type 12.7 Global High-Performance Blood and Infusion Warmer Forecast by Application 13 Key Players Analysis 13.1 Stryker 13.1.1 Stryker Company Information 13.1.2 Stryker High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.1.3 Stryker High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Stryker Main Business Overview 13.1.5 Stryker Latest Developments 13.2 Smiths Medical 13.2.1 Smiths Medical Company Information 13.2.2 Smiths Medical High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.2.3 Smiths Medical High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Smiths Medical Main Business Overview 13.2.5 Smiths Medical Latest Developments 13.3 Becton, Dickinson and Company (BD) 13.3.1 Becton, Dickinson and Company (BD) Company Information 13.3.2 Becton, Dickinson and Company (BD) High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.3.3 Becton, Dickinson and Company (BD) High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Becton, Dickinson and Company (BD) Main Business Overview 13.3.5 Becton, Dickinson and Company (BD) Latest Developments 13.4 3M Healthcare 13.4.1 3M Healthcare Company Information 13.4.2 3M Healthcare High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.4.3 3M Healthcare High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 3M Healthcare Main Business Overview 13.4.5 3M Healthcare Latest Developments 13.5 Belmont Instrument Corporation 13.5.1 Belmont Instrument Corporation Company Information 13.5.2 Belmont Instrument Corporation High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.5.3 Belmont Instrument Corporation High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Belmont Instrument Corporation Main Business Overview 13.5.5 Belmont Instrument Corporation Latest Developments 13.6 Enthermics Medical Systems 13.6.1 Enthermics Medical Systems Company Information 13.6.2 Enthermics Medical Systems High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.6.3 Enthermics Medical Systems High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Enthermics Medical Systems Main Business Overview 13.6.5 Enthermics Medical Systems Latest Developments 13.7 Barkey GmbH & Co. KG 13.7.1 Barkey GmbH & Co. KG Company Information 13.7.2 Barkey GmbH & Co. KG High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.7.3 Barkey GmbH & Co. KG High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Barkey GmbH & Co. KG Main Business Overview 13.7.5 Barkey GmbH & Co. KG Latest Developments 13.8 Smiths Group (Smiths Detection) 13.8.1 Smiths Group (Smiths Detection) Company Information 13.8.2 Smiths Group (Smiths Detection) High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.8.3 Smiths Group (Smiths Detection) High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Smiths Group (Smiths Detection) Main Business Overview 13.8.5 Smiths Group (Smiths Detection) Latest Developments 13.9 Sahajanand Medical Technologies 13.9.1 Sahajanand Medical Technologies Company Information 13.9.2 Sahajanand Medical Technologies High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.9.3 Sahajanand Medical Technologies High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Sahajanand Medical Technologies Main Business Overview 13.9.5 Sahajanand Medical Technologies Latest Developments 13.10 Parker Healthcare 13.10.1 Parker Healthcare Company Information 13.10.2 Parker Healthcare High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.10.3 Parker Healthcare High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Parker Healthcare Main Business Overview 13.10.5 Parker Healthcare Latest Developments 13.11 GE Healthcare 13.11.1 GE Healthcare Company Information 13.11.2 GE Healthcare High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.11.3 GE Healthcare High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 GE Healthcare Main Business Overview 13.11.5 GE Healthcare Latest Developments 13.12 The Surgical Company 13.12.1 The Surgical Company Company Information 13.12.2 The Surgical Company High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.12.3 The Surgical Company High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 The Surgical Company Main Business Overview 13.12.5 The Surgical Company Latest Developments 13.13 Baxter International 13.13.1 Baxter International Company Information 13.13.2 Baxter International High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.13.3 Baxter International High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Baxter International Main Business Overview 13.13.5 Baxter International Latest Developments 13.14 Inspiration Healthcare Group 13.14.1 Inspiration Healthcare Group Company Information 13.14.2 Inspiration Healthcare Group High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.14.3 Inspiration Healthcare Group High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Inspiration Healthcare Group Main Business Overview 13.14.5 Inspiration Healthcare Group Latest Developments 13.15 Stihler Electronic 13.15.1 Stihler Electronic Company Information 13.15.2 Stihler Electronic High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.15.3 Stihler Electronic High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Stihler Electronic Main Business Overview 13.15.5 Stihler Electronic Latest Developments 13.16 TahatAksi ALC 13.16.1 TahatAksi ALC Company Information 13.16.2 TahatAksi ALC High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.16.3 TahatAksi ALC High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 TahatAksi ALC Main Business Overview 13.16.5 TahatAksi ALC Latest Developments 13.17 Biegler 13.17.1 Biegler Company Information 13.17.2 Biegler High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.17.3 Biegler High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 Biegler Main Business Overview 13.17.5 Biegler Latest Developments 13.18 ACE Medical 13.18.1 ACE Medical Company Information 13.18.2 ACE Medical High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.18.3 ACE Medical High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 ACE Medical Main Business Overview 13.18.5 ACE Medical Latest Developments 13.19 Emit Corporation 13.19.1 Emit Corporation Company Information 13.19.2 Emit Corporation High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.19.3 Emit Corporation High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 Emit Corporation Main Business Overview 13.19.5 Emit Corporation Latest Developments 13.20 Foshan Keewell 13.20.1 Foshan Keewell Company Information 13.20.2 Foshan Keewell High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.20.3 Foshan Keewell High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.20.4 Foshan Keewell Main Business Overview 13.20.5 Foshan Keewell Latest Developments 13.21 Medical Technologies LBI 13.21.1 Medical Technologies LBI Company Information 13.21.2 Medical Technologies LBI High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.21.3 Medical Technologies LBI High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.21.4 Medical Technologies LBI Main Business Overview 13.21.5 Medical Technologies LBI Latest Developments 13.22 Gentherm Medical 13.22.1 Gentherm Medical Company Information 13.22.2 Gentherm Medical High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.22.3 Gentherm Medical High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.22.4 Gentherm Medical Main Business Overview 13.22.5 Gentherm Medical Latest Developments 13.23 Gamida 13.23.1 Gamida Company Information 13.23.2 Gamida High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.23.3 Gamida High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.23.4 Gamida Main Business Overview 13.23.5 Gamida Latest Developments 13.24 Midmark Animal Health 13.24.1 Midmark Animal Health Company Information 13.24.2 Midmark Animal Health High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.24.3 Midmark Animal Health High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.24.4 Midmark Animal Health Main Business Overview 13.24.5 Midmark Animal Health Latest Developments 13.25 Angel Canada Enterprises 13.25.1 Angel Canada Enterprises Company Information 13.25.2 Angel Canada Enterprises High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.25.3 Angel Canada Enterprises High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.25.4 Angel Canada Enterprises Main Business Overview 13.25.5 Angel Canada Enterprises Latest Developments 13.26 Sino Medical-Device Technology 13.26.1 Sino Medical-Device Technology Company Information 13.26.2 Sino Medical-Device Technology High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.26.3 Sino Medical-Device Technology High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.26.4 Sino Medical-Device Technology Main Business Overview 13.26.5 Sino Medical-Device Technology Latest Developments 13.27 Shenzhen Et Medical Technology 13.27.1 Shenzhen Et Medical Technology Company Information 13.27.2 Shenzhen Et Medical Technology High-Performance Blood and Infusion Warmer Product Portfolios and Specifications 13.27.3 Shenzhen Et Medical Technology High-Performance Blood and Infusion Warmer Sales, Revenue, Price and Gross Margin (2018-2023) 13.27.4 Shenzhen Et Medical Technology Main Business Overview 13.27.5 Shenzhen Et Medical Technology Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD（blood）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
